BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND Neurokinin
23 results:

  • 1. The Potential In Vitro Inhibitory Effects of neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis.
    Alsaeed MA; Ebrahimi S; Alalikhan A; Hashemi SF; Hashemy SI
    Biomed Res Int; 2022; 2022():8082608. PubMed ID: 36177059
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of the Oncology Care Model on Use of Supportive Care Medications During cancer Treatment.
    Brooks GA; Landrum MB; Kapadia NS; Liu PH; Wolf R; Riedel LE; Hsu VD; Jhatakia Parekh S; Simon C; Hassol A; Keating NL
    J Clin Oncol; 2022 Jun; 40(16):1763-1771. PubMed ID: 35213212
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study.
    Di Renzo N; Musso M; Scimè R; Cupri A; Perrone T; De Risi C; Pastore D; Guarini A; Mengarelli A; Benedetti F; Mazza P; Capria V; Chiusolo P; Cupelli L; Federico V; Bozzoli V; Messa AR; Codega P; Bonizzoni E; Specchia G
    Bone Marrow Transplant; 2020 Nov; 55(11):2114-2120. PubMed ID: 32346078
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
    Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
    Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
    Anticancer Res; 2017 Nov; 37(11):6119-6123. PubMed ID: 29061792
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
    Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
    Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells.
    Zhou Y; Zuo D; Wang M; Zhang Y; Yu M; Yang J; Yao Z
    Genes Cells; 2014 Sep; 19(9):676-91. PubMed ID: 25130457
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antiemetic control: toward a new standard of care for emetogenic chemotherapy.
    Navari RM
    Expert Opin Pharmacother; 2009 Mar; 10(4):629-44. PubMed ID: 19284365
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
    Gore L; Chawla S; Petrilli A; Hemenway M; Schissel D; Chua V; Carides AD; Taylor A; Devandry S; Valentine J; Evans JK; Oxenius B;
    Pediatr Blood Cancer; 2009 Feb; 52(2):242-7. PubMed ID: 18985740
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. neurokinin receptors as potential targets in breast cancer treatment.
    Reddy BY; Trzaska KA; Murthy RG; Navarro P; Rameshwar P
    Curr Drug Discov Technol; 2008 Mar; 5(1):15-9. PubMed ID: 18537563
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Implication of possible therapies targeted for the tachykinergic system with the biology of neurokinin receptors and emerging related proteins.
    Rameshwar P
    Recent Pat CNS Drug Discov; 2007 Jan; 2(1):79-84. PubMed ID: 18221219
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. G-coupled protein receptors and breast cancer progression: potential drug targets.
    Taborga M; Corcoran KE; Fernandes N; Ramkissoon SH; Rameshwar P
    Mini Rev Med Chem; 2007 Mar; 7(3):245-51. PubMed ID: 17346217
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma.
    Ramkissoon SH; Patel PS; Taborga M; Rameshwar P
    Cancer Res; 2007 Feb; 67(4):1653-9. PubMed ID: 17308106
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tachykinins and their receptors in human malignancies.
    Palma C
    Curr Drug Targets; 2006 Aug; 7(8):1043-52. PubMed ID: 16918332
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oncogenic and metastatic properties of preprotachykinin-I and neurokinin-1 genes.
    Singh AS; Caplan A; Corcoran KE; Fernandez JS; Preziosi M; Rameshwar P
    Vascul Pharmacol; 2006 Oct; 45(4):235-42. PubMed ID: 16901764
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential.
    Castro TA; Cohen MC; Rameshwar P
    Clin Exp Metastasis; 2005; 22(8):621-8. PubMed ID: 16642400
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis.
    Mukerji I; Ramkissoon SH; Reddy KK; Rameshwar P
    J Neurooncol; 2005 Jan; 71(2):91-8. PubMed ID: 15690122
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.
    Navari RM
    Cancer Invest; 2004; 22(4):569-76. PubMed ID: 15565815
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.